A Novel Nanozyme‐based Coordination Compound for Synergistic Periprosthetic Joint Infection Treatment and Bone Repair
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202502379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Siyu Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Biomaterials and Smart Theranostics, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Ti…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Prosthesis-Related Infections, Bone Regeneration, Coordination Complexes. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hebei Province of China, Key Talent Project of the Yanzhao Golden Platform Talent Gathering Program in Hebei Province-Postdoctoral Platform.
Abstract (Originalsprache)
Periprosthetic joint infection (PJI) represents a serious complication following joint arthroplasty, and it often results in implant failure, prolonged morbidity, and additional healthcare burdens. Current clinical strategies for PJI treatment face obstacles, including antibiotic resistance, high recurrence rate, and compromised bone repair. To address these challenges, a novel nanozyme‐based coordination compound designated as W‐GA‐Van@Zn is developed. Gallic acid decorated tungsten nanozyme (W‐GA) with dual photothermal and reactive oxygen species (ROS) scavenging ability is chosen as the core of W‐GA‐Van@Zn, and vancomycin as a bacterial targeting agent is decorated on W‐GA surface using amide reaction. After that, zinc ions are introduced and formed a metal‐phenolic coordination compound across by the polyphenolic groups on the nanozyme surface. W‐GA‐Van@Zn could achieve bacterial targeting ability through specific binding to D‐Ala‐D‐Ala moieties on the bacterial surface, and realize synergistic PJI treatment combining mild photothermal therapy (PTT) and antibiotic therapy. Meanwhile, the nanozyme could simultaneously scavenge PTT‐generated ROS, overcoming the side effect during PTT treatment. Besides, PTT‐antibiotic combination therapy reduced antibiotic dosage and provided excellent bactericidal efficacy at low antibiotic concentrations. During the bone repair stage post‐PJI treatment, the nanozyme sustained ROS scavenging to reduce inflammatory microenvironment, together with zinc ions for synergistic bone repairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei Key Laboratory of Biomaterials and Smart Theranostics, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, 300131, China.
ORCID-Profile: Huipeng Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hebei Province of China
- Key Talent Project of the Yanzhao Golden Platform Talent Gathering Program in Hebei Province-Postdoctoral Platform
- Natural Science Foundation of Tianjin of China
- National Key Research and Development Program of China
Zitieren
APA
Yang, S., Li, S., Zhang, L., Zhao, M., Zhang, T., Liu, X., Liu, B., Zhang, H., Gong, Y., Zhou, H., Li, H., & Yang, L. (2026). A Novel Nanozyme‐based Coordination Compound for Synergistic Periprosthetic Joint Infection Treatment and Bone Repair. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502379
Vancouver
Yang S, Li S, Zhang L, Zhao M, Zhang T, Liu X, et al. A Novel Nanozyme‐based Coordination Compound for Synergistic Periprosthetic Joint Infection Treatment and Bone Repair. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502379
BibTeX
@article{Yang2026,
author = {Yang, Siyu and Li, Siyu and Zhang, Long and Zhao, Mingqi and Zhang, Tingbin and Liu, Xin and Liu, Bo and Zhang, Hongze and Gong, Yiqian and Zhou, Huan and Li, Huipeng and Yang, Lei},
title = {A Novel Nanozyme‐based Coordination Compound for Synergistic Periprosthetic Joint Infection Treatment and Bone Repair},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202502379}
}
EUVIMED